SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Oberholzer L.)
 

Sökning: WFRF:(Oberholzer L.) > Phase 3 Trial of Tr...

  • Hering, Bernhard J.Univ Minnesota, Schulze Diabet Inst, Minneapolis, MN 55455 USA.;Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA. (författare)

Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia

  • Artikel/kapitelEngelska2016

Förlag, utgivningsår, omfång ...

  • 2016-04-18
  • American Diabetes Association,2016
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-308269
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-308269URI
  • https://doi.org/10.2337/dc15-1988DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • OBJECTIVE Impaired awareness of hypoglycemia (IAH) and severe hypoglycemic events (SHEs) cause substantial morbidity and mortality in patients with type 1 diabetes (T1D). Current therapies are effective in preventing SHEs in 50-80% of patients with IAH and SHEs, leaving a substantial number of patients at risk. We evaluated the effectiveness and safety of a standardized human pancreatic islet product in subjects in whom IAH and SHEs persisted despite medical treatment. RESEARCH DESIGN AND METHODS This multicenter, single-arm, phase 3 study of the investigational product purified human pancreatic islets (PHPI) was conducted at eight centers in North America. Forty-eight adults with T1D for >5 years, absent stimulated C-peptide, and documented IAH and SHEs despite expert care were enrolled. Each received immunosuppression and one or more transplants of PHPI, manufactured on-site under good manufacturing practice conditions using a common batch record and standardized lot release criteria and test methods. The primary end point was the achievement of HbA(1c) <7.0% (53 mmol/mol) at day 365 and freedom from SHEs from day 28 to day 365 after the first transplant. RESULTS The primary end point was successfully met by 87.5% of subjects at 1 year and by 71% at 2 years. The median HbA(1c) level was 5.6% (38 mmol/mol) at both 1 and 2 years. Hypoglycemia awareness was restored, with highly significant improvements in Clarke and HYPO scores (P > 0.0001). No study-related deaths or disabilities occurred. Five of the enrollees (10.4%) experienced bleeds requiring transfusions (corresponding to 5 of 75 procedures), and two enrollees (4.1%) had infections attributed to immunosuppression. Glomerular filtration rate decreased significantly on immunosuppression, and donor-specific antibodies developed in two patients. CONCLUSIONS Transplanted PHPI provided glycemic control, restoration of hypoglycemia awareness, and protection from SHEs in subjects with intractable IAH and SHEs. Safety events occurred related to the infusion procedure and immunosuppression, including bleeding and decreased renal function. Islet transplantation should be considered for patients with T1D and IAH in whom other, less invasive current treatments have been ineffective in preventing SHEs.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Clarke, William R.Univ Iowa, Clin Trials Stat & Data Management Ctr, Iowa City, IA USA. (författare)
  • Bridges, Nancy D.NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA. (författare)
  • Eggerman, Thomas L.NIDDK, NIH, Bethesda, MD 20892 USA. (författare)
  • Alejandro, RodolfoUniv Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA. (författare)
  • Bellin, Melena D.Univ Minnesota, Schulze Diabet Inst, Minneapolis, MN 55455 USA.;Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA. (författare)
  • Chaloner, KathrynUniv Iowa, Clin Trials Stat & Data Management Ctr, Iowa City, IA USA. (författare)
  • Czarniecki, Christine W.NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA. (författare)
  • Goldstein, Julia S.NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA. (författare)
  • Hunsicker, Lawrence G.Univ Iowa, Clin Trials Stat & Data Management Ctr, Iowa City, IA USA. (författare)
  • Kaufman, Dixon B.Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI USA. (författare)
  • Korsgren, OlleUppsala universitet,Klinisk immunologi(Swepub:uu)ollekors (författare)
  • Larsen, Christian P.Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA. (författare)
  • Luo, XunrongNorthwestern Univ, Feinberg Sch Med, Comprehens Transplant Ctr, Chicago, IL 60611 USA. (författare)
  • Markmann, James F.Harvard Med Sch, Massachusetts Gen Hosp, Div Transplant Surg, Boston, MA USA. (författare)
  • Naji, AliUniv Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.;Univ Penn, Perelman Sch Med, Dept Surg, Philadelphia, PA 19104 USA.;Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA. (författare)
  • Oberholzer, JoseUniv Illinois Hosp & Hlth Sci Syst, Div Transplantat, Chicago, IL USA. (författare)
  • Posselt, Andrew M.Univ Calif San Francisco, Dept Surg, San Francisco, CA USA. (författare)
  • Rickels, Michael R.Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.;Univ Penn, Perelman Sch Med, Dept Surg, Philadelphia, PA 19104 USA.;Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA. (författare)
  • Ricordi, CamilloUniv Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA. (författare)
  • Robien, Mark A.NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA. (författare)
  • Senior, Peter A.Univ Alberta, Clin Islet Transplant Program, Edmonton, AB, Canada.;Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada. (författare)
  • Shapiro, A. M. JamesUniv Alberta, Clin Islet Transplant Program, Edmonton, AB, Canada.;Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada. (författare)
  • Stock, Peter G.Univ Calif San Francisco, Dept Surg, San Francisco, CA USA. (författare)
  • Turgeon, Nicole A.Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA. (författare)
  • Univ Minnesota, Schulze Diabet Inst, Minneapolis, MN 55455 USA.;Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA.Univ Iowa, Clin Trials Stat & Data Management Ctr, Iowa City, IA USA. (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Diabetes Care: American Diabetes Association39:7, s. 1230-12400149-59921935-5548

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy